Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Woman's 5-year struggle with balance and walking was caused by a 'one-in-a-million' disorder
A woman developed severe stiffness in her knees, along with a range of other symptoms. Blood tests revealed her very rar...
Now is the best time to see Saturn all year — yes, even with the naked eye
Saturn will put on a show this week as it enters opposition and its famous rings return to looking their best.
Young minds develop ideas to tackle climate change
Image source, Jon Wright/BBCImage caption, Baveen and Shanice focused on ideas to combat light pollution at the hackatho...
Trump can't stop America's shift to clean energy. And we can accelerate it.
The cost of clean energy just keeps falling as the price of coal ramps up. Politicians promising affordability will foll...